Language impairment is associated with faster progression in progressive supranuclear palsy‐Richardson syndrome is a research paper published in Alzheimer s & Dementia (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute on Aging
Grant: K99AG073453
National Institutes of Health
Grant: R21DC019749
National Institutes of Health
Grant: K23 NS118045
National Institutes of Health
Grant: 5U01NS112010/807745
National Institutes of Health
Grant: U01NS100610
National Institutes of Health
Grant: R25NS098999
National Institutes of Health
Grant: U19 AG063911‐1
National Institutes of Health
Grant: 1R21NS114764‐01A1
National Institutes of Health
Grant: 2 P30 AG062429‐06
NIH HHS
Grant: 1R21NS114764-01A1
Real-Time L-Dopa Monitoring for Improved Management of Parkinson Disease
NIH HHS
Grant: U19 AG063911-1
NIH HHS
Grant: 2 P30 AG062429-06
NINDS NIH HHS
Grant: K23 NS121402
NIA NIH HHS
Grant: P30 AG066507
NIA/NIH
Grant: R44AG080861
NIA NIH HHS
Grant: R00 AG073453
NIA/NIH
Grant: R01AG085029
National Institutes of Health
Grant: 3R44AG080861-02S1
A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration Syndromes
National Institutes of Health
Grant: 5K23NS118045-05
Clinical trial readiness in X-linked dystonia parkinsonism: assessment of sensor-based and blood biomarkers for early detection and monitoring disease progression
National Institutes of Health
Grant: 1U01NS112010-01
Assessing skin biomarkers for preclinical diagnosis of PD and non-PD Parkinsonism
National Institutes of Health
Grant: 1U01NS100610-01
Dementia with Lewy Bodies Consortium
National Institutes of Health
Grant: 3U19AG063911-06S4
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)
National Institutes of Health
Grant: 5K23NS121402-03
Cerebellar TMS for postural instability in progressive supranuclear palsy
National Institutes of Health
Grant: 1R21DC019749-01A1
Defining the role of the subthalamic nucleus in language production through deep brain stimulation
National Institutes of Health
Grant: 5R01AG085029-02
The Progressive Supranuclear Palsy Clinical Trial Platform (PTP)
National Institutes of Health
Grant: 5K99AG073453-02
Genetic and Neuropathologic Underpinnings of Sex Differences in Lewy Body Dementias
National Institutes of Health
Grant: 5P30AG062429-03
UCSD Alzheimer's Disease Research Centers P30
National Institutes of Health
Grant: 5R25NS098999-02
Training in Research for Academic Neurologists to Sustain Careers and Enhance the Numbers of Diverse Scholars (TRANSCENDS)
American Brain Foundation
Genentech
Holloway Family Fund of The Association for Frontotemporal Degeneration
Parkinson's Foundation
Rutgers University Press
Sanofi-Genzyme, SwanBio therapeutics and Encora Therapeutics
AbbVie
Cambridge University Press
Lewy Body Dementia Association
School of Public Health, University of California Berkeley
Parkinson's Foundation
Vivli, Inc
BIA R&D
Biogen Inc.
Biogen and Biohaven
Ono Pharmaceuticals, Accordant and CVS/Caremark
Alterity
Biogen
Novartis
UCB
American Academy of Neurology
CurePSP
International Parkinson and Movement Disorders Society
Marion and Gerald Soloway Chair in Brain Injury and Concussion Research
Michael J Fox Foundation
Sage Therapeutics
Alzheimer's Association Clinician Scientist Fellowship
H. Lundbeck A/S
Lundbeck
EIP-Pharma
MedRhythms, Inc
Roche
FWCI
2.31
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals